BCM
MIRM icon

Burrage Capital Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Burrage Capital Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-205,866
Closed -$3.56M – 12
2021
Q2 		$3.56M Hold
205,866
– – 3.57% 13
2021
Q1 		$4.08M Buy
205,866
+44,238
+27% +$847K 3.31% 13
2020
Q4 		$2.82M Buy
+161,628
New +$3.18M 2.15% 20

Other funds holding MIRM

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Burrage Capital Management's MIRM Position: Q3 2021 in Review

Burrage Capital Management sold out of Mirum Pharmaceuticals (MIRM) in Q3 2021, closing a stake of 205,866 shares — an estimated $3.56M sold.

Burrage Capital Management first reported a position in MIRM in Q4 2020 and held it in 3 quarters. The position peaked at $4.08M in Q1 2021. 73 funds tracked by Wall St. Rank hold MIRM as of Q3 2021.

  • Burrage Capital Management reported no remaining Mirum Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Burrage Capital Management sold 205,866 Mirum Pharmaceuticals shares in Q3 2021, an estimated $3.56M.
  • Burrage Capital Management first reported a position in Mirum Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • Burrage Capital Management's Mirum Pharmaceuticals position peaked at $4.08M in Q1 2021.
  • 73 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q3 2021.

Based on Burrage Capital Management's 13F filing for Q3 2021.